GlassScriptPhysician profile
Eveleigh E Williams
NPI 1629080742
$7,590.85
in general payments reported to CMS, 2019-2025
29 companies · $2,652 in 2025
The $2,652 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,525 · 2020: $132 · 2021: $387 · 2022: $181 · 2023: $1,967 · 2024: $746 · 2025: $2,652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,292 · Food and Beverage: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,292.42 |
| Food and Beverage | $2,072.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,548.96 | 2023 | Na |
| Lifenet Health | $1,362.62 | 2023-2025 | Theragenesis Wound Matrix |
| Treace Medical Concepts, INC. | $1,199.43 | 2019-2025 | |
| Amniox Medical, INC. | $1,013.12 | 2019 | |
| Arthrex, INC. | $288.20 | 2025 | |
| Lightbody Medical Technologies INC | $275.94 | 2024-2025 | |
| Depuy Synthes Sales INC. | $273.62 | 2023-2024 | Motoband, Minibunion, N/A |
| Zimmer Biomet Holdings, INC. | $260.58 | 2020-2021 | |
| Stryker Corporation | $217.86 | 2020-2025 | Limflow System, Phalinx, Sonicanchor |
| Amgen INC. | $182.53 | 2024 | Krystexxa |
| Organogenesis INC. | $167.09 | 2022-2024 | |
| Paratek Pharmaceuticals, INC. | $164.26 | 2024-2025 | Nuzyra |
| Horizon Therapeutics Plc | $128.45 | 2023 | Krystexxa |
| Smith+Nephew, INC. | $66.18 | 2019-2025 | Collagenase Santyl, Grafix |
| Mimedx Group, INC. | $47.37 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $40.72 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Janssen Biotech, INC. | $40.00 | 2025 | |
| Polynovo North America LLC | $39.95 | 2022-2023 | |
| Orthofix Medical, INC. | $33.26 | 2024 | Physio-Stim |
| Osteomed LLC | $32.20 | 2020-2021 | |
| Acumed LLC | $29.88 | 2025 | Acumed |
| Fusion Orthopedics USA, LLC | $27.70 | 2024-2025 | |
| Convatec INC. | $27.26 | 2025 | |
| Surgenex LLC | $27.15 | 2025 | Surgraft, Ardeograft, Renograft |
| Next Science LLC | $25.83 | 2023 | Surgx, Blastx, Xperience |
| Abbott Laboratories | $19.95 | 2025 | Proclaim |
| Medwest Associates | $18.90 | 2021 | |
| Kerecis Limited | $18.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pacira Pharmaceuticals Incorporated | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eveleigh Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.